Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Human immunodeficiency virus 1 | Aberrant vpr protein | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | transcription factor SMAD2 | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Schistosoma japonicum | ko:K04380 microtubule-associated protein tau, putative | Get druggable targets OG5_133504 | All targets in OG5_133504 |
Brugia malayi | MH2 domain containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Echinococcus multilocularis | microtubule associated protein 2 | Get druggable targets OG5_133504 | All targets in OG5_133504 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | Get druggable targets OG5_149948 | All targets in OG5_149948 |
Echinococcus granulosus | microtubule associated protein 2 | Get druggable targets OG5_133504 | All targets in OG5_133504 |
Loa Loa (eye worm) | MH2 domain-containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Schistosoma mansoni | microtubule-associated protein tau | Get druggable targets OG5_133504 | All targets in OG5_133504 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | nmda type glutamate receptor | 0.0476 | 0.5287 | 0.5287 |
Schistosoma mansoni | glutamate receptor kainate | 0.0204 | 0.1695 | 0.1695 |
Echinococcus multilocularis | glutamate (NMDA) receptor subunit | 0.0484 | 0.5396 | 0.5396 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0243 | 0.2205 | 0.2205 |
Echinococcus granulosus | glutamate receptor ionotrophic AMPA 3 | 0.0243 | 0.2205 | 0.2205 |
Schistosoma mansoni | glutamate receptor kainate | 0.0204 | 0.1695 | 0.1695 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0243 | 0.2205 | 0.2205 |
Loa Loa (eye worm) | glutamate receptor 2 | 0.0204 | 0.1695 | 1 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0243 | 0.2205 | 0.2205 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0439 | 0.4801 | 0.4801 |
Echinococcus multilocularis | glutamate receptor, ionotrophic, AMPA 3 | 0.0243 | 0.2205 | 0.2205 |
Echinococcus multilocularis | glutamate receptor 2 | 0.0167 | 0.121 | 0.121 |
Echinococcus multilocularis | glutamate receptor 2 | 0.0243 | 0.2205 | 0.2205 |
Echinococcus multilocularis | glutamate receptor NMDA | 0.0401 | 0.4291 | 0.4291 |
Echinococcus granulosus | glutamate receptor NMDA | 0.0401 | 0.4291 | 0.4291 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 1 | 1 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0243 | 0.2205 | 0.2205 |
Schistosoma mansoni | glutamate receptor NMDA | 0.0643 | 0.7492 | 0.7492 |
Brugia malayi | Glutamate receptor 2 precursor | 0.0204 | 0.1695 | 1 |
Schistosoma mansoni | glutamate receptor AMPA | 0.0204 | 0.1695 | 0.1695 |
Schistosoma mansoni | glutamate receptor kainate | 0.0204 | 0.1695 | 0.1695 |
Echinococcus granulosus | glutamate NMDA receptor subunit | 0.0484 | 0.5396 | 0.5396 |
Echinococcus granulosus | glutamate receptor 2 | 0.0167 | 0.121 | 0.121 |
Loa Loa (eye worm) | glutamate receptor 1 | 0.0204 | 0.1695 | 1 |
Brugia malayi | Glutamate receptor 1 precursor | 0.0204 | 0.1695 | 1 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0278 | 0.267 | 0.5 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0476 | 0.5287 | 0.5287 |
Schistosoma mansoni | ATP-binding cassette transporter | 0.0204 | 0.1695 | 0.1695 |
Echinococcus granulosus | glutamate receptor 2 | 0.0243 | 0.2205 | 0.2205 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0243 | 0.2205 | 0.2205 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0439 | 0.4801 | 0.4801 |
Schistosoma mansoni | glutamate receptor AMPA | 0.0204 | 0.1695 | 0.1695 |
Schistosoma mansoni | glutamate receptor NMDA | 0.0484 | 0.5396 | 0.5396 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 1 | 1 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0243 | 0.2205 | 0.2205 |
Echinococcus multilocularis | glutamate receptor 2 | 0.0204 | 0.1695 | 0.1695 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.1 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 1.122 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 7.9433 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.